🇺🇸 FDA
Patent

US 6790449

Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

expired A61KA61K2039/525A61K39/00

Quick answer

US patent 6790449 (Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/525, A61K39/00, A61P, A61P31/14